Mark E. Smulson
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Research Interests
Mark E. Smulson has a total of 33 co-authors. Here are the top co-authors by number of shared publications:
- Cynthia Marie Simbulan-Rosenthal
Department of Biochemistry and Molecular & Cellular Biology, Georgetown University School of Medicine, Washington, DC 20057, USA
7 shared publications A. Hamid Boulares
Department of Biochemistry and Molecular Biology, Georgetown University School of Medicine, Washington, DC 20007, USA
5 shared publications- Bogdan A. Stoica
Department of Anesthesiology and Shock, Trauma and Anesthesiology Research (STAR) Center, University of Maryland School of Medicine, Baltimore, MD, USA
4 shared publications Sudha Iyer
Department of Biochemistry and Molecular Biology, Georgetown University School of Medicine, Washington, D.C, 20007
3 shared publicationsAnna J. Zoltoski
Department of Biochemistry and Molecular Biology, Georgetown University School of Medicine, Washington, DC 20007, U.S.A.
2 shared publicationsR Luo
2 shared publications
Latest Publications
- 1 January 2002
- Published by Wiley in Basic & Clinical Pharmacology & Toxicology
- Vol. 90 (1) , 38-50
Acetaminophen Induces a Caspase‐Dependent and Bcl‐xLSensitive Apoptosis in Human Hepatoma Cells and Lymphocytes
Acetaminophen is a widely used analgesic and antipyretic drug that exhibits toxicity at high doses to the liver and kidneys. This toxicity has been attributed to cytochrome P‐450‐generated metabolites which covalently modify target proteins. Recently, acetaminophen, in its unmetabolized form, has been shown to affect a variety of cells and tissues, for instance, testicular and lymphoid tissues and lymphocyte cell lines. The effects on cell viability of acetaminophen at a concentration comparable to that achieved in plasma during acetaminophen toxicity have now been examined with a hepatoma cell line SK‐Hep1, primary human peripheral blood lymphocytes and human Jurkat T cells. Acetaminophen reduced cell viability in a time‐dependent manner. Staining of cells with annexin‐V also revealed that acetaminophen induced, after 8 hr of treatment, a loss of the asymmetry of membrane phospholipids, which is an early event associated with apoptosis. Acetaminophen triggered the release of cytochrome c from mitochondria into the cytosol, activation of caspase‐3, 8, and 9, cleavage of poly(ADP‐ribose) polymerase, and degradation of lamin B1and DNA. Whereas cleavage of DNA into internucleosomal fragments was apparent in acetaminophen treated SK‐Hep1 and primary lymphocytes, DNA was only degraded to 50‐kb fragments in treated Jurkat cells. Overexpression of the antiapoptotic protein Bcl‐xLprevented these various apoptotic events induced by acetaminophen in Jurkat cells. Caspase‐8 activation was a postmictochondrial event and occurred in a Fas‐independent manner. These results demonstrate that acetaminophen induces caspases‐dependent apoptosis with mitochondria as a primary target. These results also reiterate the potential role of apoptosis in acetaminophen hepatic and extrahepatic toxicity.
- 1 January 2002
- Published by Wiley in Basic & Clinical Pharmacology & Toxicology
- Vol. 90 (1) , 38-50
Acetaminophen Induces a Caspase‐Dependent and Bcl‐xLSensitive Apoptosis in Human Hepatoma Cells and Lymphocytes
Acetaminophen is a widely used analgesic and antipyretic drug that exhibits toxicity at high doses to the liver and kidneys. This toxicity has been attributed to cytochrome P‐450‐generated metabolites which covalently modify target proteins. Recently, acetaminophen, in its unmetabolized form, has been shown to affect a variety of cells and tissues, for instance, testicular and lymphoid tissues and lymphocyte cell lines. The effects on cell viability of acetaminophen at a concentration comparable to that achieved in plasma during acetaminophen toxicity have now been examined with a hepatoma cell line SK‐Hep1, primary human peripheral blood lymphocytes and human Jurkat T cells. Acetaminophen reduced cell viability in a time‐dependent manner. Staining of cells with annexin‐V also revealed that acetaminophen induced, after 8 hr of treatment, a loss of the asymmetry of membrane phospholipids, which is an early event associated with apoptosis. Acetaminophen triggered the release of cytochrome c from mitochondria into the cytosol, activation of caspase‐3, 8, and 9, cleavage of poly(ADP‐ribose) polymerase, and degradation of lamin B1and DNA. Whereas cleavage of DNA into internucleosomal fragments was apparent in acetaminophen treated SK‐Hep1 and primary lymphocytes, DNA was only degraded to 50‐kb fragments in treated Jurkat cells. Overexpression of the antiapoptotic protein Bcl‐xLprevented these various apoptotic events induced by acetaminophen in Jurkat cells. Caspase‐8 activation was a postmictochondrial event and occurred in a Fas‐independent manner. These results demonstrate that acetaminophen induces caspases‐dependent apoptosis with mitochondria as a primary target. These results also reiterate the potential role of apoptosis in acetaminophen hepatic and extrahepatic toxicity.
- Open Access
- 1 October 2001
- Published by American Society for Biochemistry & Molecular Biology (ASBMB) in Journal of Biological Chemistry
- Vol. 276 (41) , 38185-38192
Roles of DNA Fragmentation Factor and Poly(ADP-ribose) Polymerase in an Amplification Phase of Tumor Necrosis Factor-induced Apoptosis
During apoptosis, endonucleases cleave DNA into 50–300-kb fragments and subsequently into internucleosomal fragments. DNA fragmentation factor (DFF) is implicated in apoptotic DNA cleavage; this factor comprises DFF45 and DFF40 subunits, the former of which acts as a chaperone and inhibitor of the catalytic subunit and whose cleavage by caspase-3 results in DFF activation. Disruption of the DFF45 gene blocks internucleosomal DNA fragmentation and confers resistance to apoptosis in primary thymocytes. The role of DFF-mediated DNA fragmentation in apoptosis was investigated in primary fibroblasts from DFF45−/−and control (DFF45+/+) mice. DFF45 deficiency rendered fibroblasts resistant to apoptosis induced by tumor necrosis factor (TNF). TNF induced rapid cleavage of DNA into ∼50-kb fragments in DFF45+/+ fibroblasts but not in DFF45−/−cells, indicating that DFF mediates this initial step in DNA processing. The TNF-induced activation of poly(ADP-ribose) polymerase (PARP), which requires PARP binding to DNA strand breaks, and the consequent depletion of the PARP substrate NAD were markedly delayed in DFF45−/− cells, suggesting a role for DFF in PARP activation. The activation of caspase-3 and mitochondrial events important in apoptotic signaling, including the loss of mitochondrial membrane potential and the release of cytochrome c, induced by TNF were similarly delayed in DFF45−/− fibroblasts. DFF45−/− and DFF45+/+ cells were equally sensitive to the DNA-damaging agent and PARP activatorN-methyl-N′-nitro-N-nitrosoguanidine. Inhibition of PARP by 3-aminobenzamide partially protected DFF45+/+ cells against TNF-induced death and inhibited the associated release of cytochrome c and activation of caspase-3. These results suggest that the generation of 50-kb DNA fragments by DFF, together with the activation of PARP, mitochondrial dysfunction, and caspase-3 activation, contributes to an amplification loop in the death process.
- 1 October 2001
- Published by American Society for Biochemistry & Molecular Biology (ASBMB) in Journal of Biological Chemistry
- Vol. 276 (41) , 38185-38192
Open AccessRoles of DNA Fragmentation Factor and Poly(ADP-ribose) Polymerase in an Amplification Phase of Tumor Necrosis Factor-induced Apoptosis
During apoptosis, endonucleases cleave DNA into 50–300-kb fragments and subsequently into internucleosomal fragments. DNA fragmentation factor (DFF) is implicated in apoptotic DNA cleavage; this factor comprises DFF45 and DFF40 subunits, the former of which acts as a chaperone and inhibitor of the catalytic subunit and whose cleavage by caspase-3 results in DFF activation. Disruption of the DFF45 gene blocks internucleosomal DNA fragmentation and confers resistance to apoptosis in primary thymocytes. The role of DFF-mediated DNA fragmentation in apoptosis was investigated in primary fibroblasts from DFF45−/−and control (DFF45+/+) mice. DFF45 deficiency rendered fibroblasts resistant to apoptosis induced by tumor necrosis factor (TNF). TNF induced rapid cleavage of DNA into ∼50-kb fragments in DFF45+/+ fibroblasts but not in DFF45−/−cells, indicating that DFF mediates this initial step in DNA processing. The TNF-induced activation of poly(ADP-ribose) polymerase (PARP), which requires PARP binding to DNA strand breaks, and the consequent depletion of the PARP substrate NAD were markedly delayed in DFF45−/− cells, suggesting a role for DFF in PARP activation. The activation of caspase-3 and mitochondrial events important in apoptotic signaling, including the loss of mitochondrial membrane potential and the release of cytochrome c, induced by TNF were similarly delayed in DFF45−/− fibroblasts. DFF45−/− and DFF45+/+ cells were equally sensitive to the DNA-damaging agent and PARP activatorN-methyl-N′-nitro-N-nitrosoguanidine. Inhibition of PARP by 3-aminobenzamide partially protected DFF45+/+ cells against TNF-induced death and inhibited the associated release of cytochrome c and activation of caspase-3. These results suggest that the generation of 50-kb DNA fragments by DFF, together with the activation of PARP, mitochondrial dysfunction, and caspase-3 activation, contributes to an amplification loop in the death process.
- 1 March 2001
- Published by Elsevier in Toxicology and Applied Pharmacology
- Vol. 171 (2) , 94-106
Mechanisms of JP-8 Jet Fuel Toxicity. I. Induction of Apoptosis in Rat Lung Epithelial Cells
- 1 March 2001
- Published by Elsevier in Toxicology and Applied Pharmacology
- Vol. 171 (2) , 94-106
Mechanisms of JP-8 Jet Fuel Toxicity. I. Induction of Apoptosis in Rat Lung Epithelial Cells
- Open Access
Poly(ADP-ribosyl)ation of p53 In Vitro and In Vivo Modulates Binding to its DNA Consensus Sequence
- 3 October 2000
- Published by National Academy of Sciences in Proceedings of the National Academy of Sciences
- Vol. 97 (21) , 11274-11279
Misregulation of gene expression in primary fibroblasts lacking poly(ADP-ribose) polymerase
Poly(ADP-ribose) polymerase (PARP) is implicated in the maintenance of genomic integrity, given that inhibition or depletion of this enzyme increases genomic instability in cells exposed to genotoxic agents. We previously showed that immortalized fibroblasts derived from PARP −/− mice exhibit an unstable tetraploid population, and partial chromosomal gains and losses in PARP −/− mice and immortalized fibroblasts are accompanied by changes in the expression of p53, Rb, and c-Jun, as well as other proteins. A tetraploid population has also now been detected in primary fibroblasts derived from PARP −/− mice. Oligonucleotide microarray analysis was applied to characterize more comprehensively the differences in gene expression between asynchronously dividing primary fibroblasts derived from PARP −/− mice and their wild-type littermates. Of the 11,000 genes monitored, 91 differentially expressed genes were identified. The loss of PARP results in down-regulation of the expression of several genes involved in regulation of cell cycle progression or mitosis, DNA replication, or chromosomal processing or assembly. PARP deficiency also up-regulates genes that encode extracellular matrix or cytoskeletal proteins that are implicated in cancer initiation or progression or in normal or premature aging. These results provide insight into the mechanism by which PARP deficiency impairs mitotic function, thereby resulting in the genomic alterations and chromosomal abnormalities as well as in altered expression of genes that may contribute to genomic instability, cancer, and aging.
- 3 October 2000
- Published by National Academy of Sciences in Proceedings of the National Academy of Sciences
- Vol. 97 (21) , 11274-11279
Misregulation of gene expression in primary fibroblasts lacking poly(ADP-ribose) polymerase
Poly(ADP-ribose) polymerase (PARP) is implicated in the maintenance of genomic integrity, given that inhibition or depletion of this enzyme increases genomic instability in cells exposed to genotoxic agents. We previously showed that immortalized fibroblasts derived from PARP −/− mice exhibit an unstable tetraploid population, and partial chromosomal gains and losses in PARP −/− mice and immortalized fibroblasts are accompanied by changes in the expression of p53, Rb, and c-Jun, as well as other proteins. A tetraploid population has also now been detected in primary fibroblasts derived from PARP −/− mice. Oligonucleotide microarray analysis was applied to characterize more comprehensively the differences in gene expression between asynchronously dividing primary fibroblasts derived from PARP −/− mice and their wild-type littermates. Of the 11,000 genes monitored, 91 differentially expressed genes were identified. The loss of PARP results in down-regulation of the expression of several genes involved in regulation of cell cycle progression or mitosis, DNA replication, or chromosomal processing or assembly. PARP deficiency also up-regulates genes that encode extracellular matrix or cytoskeletal proteins that are implicated in cancer initiation or progression or in normal or premature aging. These results provide insight into the mechanism by which PARP deficiency impairs mitotic function, thereby resulting in the genomic alterations and chromosomal abnormalities as well as in altered expression of genes that may contribute to genomic instability, cancer, and aging.
- 1 June 2000
- Published by Elsevier in Advances in Enzyme Regulation
- Vol. 40 (1) , 183-215
Roles of poly(ADP-ribosyl)ation and PARP in apoptosis, DNA repair, genomic stability and functions of p53 and E2F-1
- 1 June 2000
- Published by Elsevier in Advances in Enzyme Regulation
- Vol. 40 (1) , 183-215
Roles of poly(ADP-ribosyl)ation and PARP in apoptosis, DNA repair, genomic stability and functions of p53 and E2F-1
- Open Access
- 1 August 1999
- Published by Elsevier in Journal of Biological Chemistry
- Vol. 274 (33) , 22932-22940
Role of Poly(ADP-ribose) Polymerase (PARP) Cleavage in Apoptosis
- 1 August 1999
- Published by Elsevier in Journal of Biological Chemistry
- Vol. 274 (33) , 22932-22940
Open AccessRole of Poly(ADP-ribose) Polymerase (PARP) Cleavage in Apoptosis
- 1 May 1999
- Vol. 59 (9) , 2190-4
Poly(ADP-ribosyl)ation of p53 during apoptosis in human osteosarcoma cells.
Spontaneous apoptosis in human osteosarcoma cells was observed to be associated with a marked increase in the intracellular abundance of p53. Immunoprecipitation and immunoblot analysis revealed that, together with a variety of other nuclear proteins, p53 undergoes extensive poly(ADP-ribosyl)ation early during the apoptotic program in these cells. Subsequent degradation of poly(ADP-ribose) (PAR), attached to p53 presumably by PAR glycohydrolase, the only reported enzyme to degrade PAR, was apparent concomitant with the onset of proteolytic processing and activation of caspase-3, caspase-3-mediated cleavage of poly(ADP-ribose) polymerase (PARP), and internucleosomal DNA fragmentation during the later stages of cell death. The decrease in PAR covalently bound to p53 also coincided with the marked induction of expression of the p53-responsive genes bax and Fas. These results suggest that poly(ADP-ribosyl)ation may play a role in the regulation of p53 function and implies a regulatory role for PARP and/or PAR early in apoptosis.
- 1 May 1999
- Vol. 59 (9) , 2190-4
Poly(ADP-ribosyl)ation of p53 during apoptosis in human osteosarcoma cells.
Spontaneous apoptosis in human osteosarcoma cells was observed to be associated with a marked increase in the intracellular abundance of p53. Immunoprecipitation and immunoblot analysis revealed that, together with a variety of other nuclear proteins, p53 undergoes extensive poly(ADP-ribosyl)ation early during the apoptotic program in these cells. Subsequent degradation of poly(ADP-ribose) (PAR), attached to p53 presumably by PAR glycohydrolase, the only reported enzyme to degrade PAR, was apparent concomitant with the onset of proteolytic processing and activation of caspase-3, caspase-3-mediated cleavage of poly(ADP-ribose) polymerase (PARP), and internucleosomal DNA fragmentation during the later stages of cell death. The decrease in PAR covalently bound to p53 also coincided with the marked induction of expression of the p53-responsive genes bax and Fas. These results suggest that poly(ADP-ribosyl)ation may play a role in the regulation of p53 function and implies a regulatory role for PARP and/or PAR early in apoptosis.
- 15 October 1998
- Vol. 58 (20) , 4510-4
Induction of apoptosis in proliferating human endothelial cells by the tumor-specific antiangiogenesis agent combretastatin A-4.
The antiangiogenic, tubulin-binding drug combretastatin A-4 exhibits a selective toxicity for proliferating endothelial cells in vitro and induces vascular shutdown in tumor models in vivo. The mechanism of combretastatin A-4 cytotoxicity has now been investigated with cultured proliferating human umbilical vein endothelial cells by examining various markers of apoptosis. Incubation of cells with 0.1 mM combretastatin A-4 induced the conversion (first detected after 6 h) of the CPP32 proenzyme to active caspase-3, a cysteine protease that plays an important role in apoptosis in many cell types; the drug also increased caspase-3 activity. Another early event observed was the binding of annexin V to 50% of the cells 8 h after drug treatment. Internucleosomal DNA fragmentation, another hallmark of apoptosis, was detected in cells incubated with 0.1 mM combretastatin A-4 for 24 h. Staining with Hoechst 33258 revealed that about 75% of cells exhibited a nuclear morphology characteristic of apoptosis after incubation with drug for 24 h. Incubation of cells for up to 8 h with combretastatin A-4 did not induce the release of lactate dehydrogenase or increase the uptake of propidium iodide, both indicators of membrane integrity. These results indicate that the selective cytotoxic effect of combretastatin A-4 is mediated by the induction of apoptosis rather than by necrosis and may provide an enhanced clinical strategy in cancer chemotherapy with this new agent.
- 15 October 1998
- Vol. 58 (20) , 4510-4
Induction of apoptosis in proliferating human endothelial cells by the tumor-specific antiangiogenesis agent combretastatin A-4.
The antiangiogenic, tubulin-binding drug combretastatin A-4 exhibits a selective toxicity for proliferating endothelial cells in vitro and induces vascular shutdown in tumor models in vivo. The mechanism of combretastatin A-4 cytotoxicity has now been investigated with cultured proliferating human umbilical vein endothelial cells by examining various markers of apoptosis. Incubation of cells with 0.1 mM combretastatin A-4 induced the conversion (first detected after 6 h) of the CPP32 proenzyme to active caspase-3, a cysteine protease that plays an important role in apoptosis in many cell types; the drug also increased caspase-3 activity. Another early event observed was the binding of annexin V to 50% of the cells 8 h after drug treatment. Internucleosomal DNA fragmentation, another hallmark of apoptosis, was detected in cells incubated with 0.1 mM combretastatin A-4 for 24 h. Staining with Hoechst 33258 revealed that about 75% of cells exhibited a nuclear morphology characteristic of apoptosis after incubation with drug for 24 h. Incubation of cells for up to 8 h with combretastatin A-4 did not induce the release of lactate dehydrogenase or increase the uptake of propidium iodide, both indicators of membrane integrity. These results indicate that the selective cytotoxic effect of combretastatin A-4 is mediated by the induction of apoptosis rather than by necrosis and may provide an enhanced clinical strategy in cancer chemotherapy with this new agent.
- Open Access
- 1 May 1998
- Published by Elsevier in Journal of Biological Chemistry
- Vol. 273 (22) , 13703-13712
Transient Poly(ADP-ribosyl)ation of Nuclear Proteins and Role of Poly(ADP-ribose) Polymerase in the Early Stages of Apoptosis
- 1 May 1998
- Published by Elsevier in Journal of Biological Chemistry
- Vol. 273 (22) , 13703-13712
Open AccessTransient Poly(ADP-ribosyl)ation of Nuclear Proteins and Role of Poly(ADP-ribose) Polymerase in the Early Stages of Apoptosis